Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-3.14M.
ENTERPRISE VALUE (EV)
$-3.14M
Imunon, Inc.
Market Cap
$5.04M
Enterprise Value (EV)
$-3.14M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Imunon, Inc. (IMNN) | $5.04M | $-3.14M |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.17M | $11.79M |
| Lunai Bioworks Inc. (LNAI)vs › | $5.17M | $3.42M |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.17M | $3.60M |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | $3.07M |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | $3.07M |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.82M | $1.43M |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | $8.73M |
| CalciMedica, Inc. (CALC)vs › | $4.66M | N/A |
Market Cap
$5.04M
Total Debt
$602000.00
Cash
$8.78M
Enterprise Value
$-3.14M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
